Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Minerva Endocrinologica

• Publication date

  2016-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 26505694PMCID PMC5079753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycemic changes after gastrectomy in non-morbidly obese patients with gastric cancer and diabetes.

  2015cited by this paper
• Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

  2015influential reference
• Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.

  2015cited by this paper
• Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial.

  2015cited by this paper
• Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.

  2015cited by this paper
• Comparison of results after one year between sleeve gastrectomy and gastric bypass in patients with BMI ≥ 50 kg/m².

  2015cited by this paper
• GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

  2015cited by this paper
• Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium

  2015cited by this paper
• Comparison of the Effectiveness of Four Bariatric Surgery Procedures in Obese Patients with Type 2 Diabetes: A Retrospective Study

  2014cited by this paper
• Dynamics of type 2 diabetes mellitus laboratory remission after Roux-en-Y gastric bypass in patients with body mass index lower than 35 kg/m2 and higher than 35 kg/m2 in a 3-year observation period

  2014cited by this paper
• Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-En-Y Gastric Bypass for Morbid Obesity and Related Comorbidities: A Meta-Analysis of 21 Studies

  2014cited by this paper
• Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass.

  2014cited by this paper
• Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment.

  2014cited by this paper
• Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass?

  2013influential reference
• Changes in GIP gene expression following bariatric surgery

  2013cited by this paper
• Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy?

  2013cited by this paper
• Aromatic L-amino acid decarboxylase deficiency is a cause of long-fasting hypoglycemia.

  2013cited by this paper
• Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models

  2013cited by this paper
• Significant Weight Loss and Rapid Resolution of Diabetes and Dyslipidemia During Short-Term Follow-Up After Laparoscopic Sleeve Gastrectomy

  2013cited by this paper
• Impact of Roux-en-Y gastric bypass on regulation of diabetes type 2 in morbidly obese patients

  2012cited by this paper
• Metabolic/bariatric surgery

  2012cited by this paper
• Bariatric surgery versus conventional medical therapy for type 2 diabetes.

  2012cited by this paper
• The role of glycogen synthase in the development of hyperglycemia in type 2 diabetes – ‘To store or not to store glucose, that's the question’

  2012cited by this paper
• [Bariatric surgery versus conventional medical therapy for type 2 diabetes].

  2012cited by this paper
• Exogenous and endogenous ghrelin counteracts GLP‐1 action to stimulate cAMP signaling and insulin secretion in islet β‐cells

  2012cited by this paper
• Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes

  2012cited by this paper
• Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with One Anastomosis Gastric Bypass.

  2012cited by this paper
• Outcome after gastrectomy in gastric cancer patients with type 2 diabetes.

  2012cited by this paper
• Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro.

  2012cited by this paper
• Dopamine synthesis and D3 receptor activation in pancreatic β-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations.

  2012cited by this paper
• Pancreatic Beta Cell Mass PET Imaging and Quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in Rodent Models of Diabetes

  2011cited by this paper
• Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

  2011cited by this paper
• First Report from the American College of Surgeons Bariatric Surgery Center Network: Laparoscopic Sleeve Gastrectomy has Morbidity and Effectiveness Positioned Between the Band and the Bypass

  2011cited by this paper
• Gastric Bypass in the Treatment of Type 2 Diabetes in Patients with a BMI of 30 to 35 kg/m2

  2011cited by this paper
• Innervation patterns of autonomic axons in the human endocrine pancreas.

  2011cited by this paper
• Laparoscopic Roux-en-Y Gastric Bypass for the Treatment of Type II Diabetes Mellitus in Chinese Patients with Body Mass Index of 25–35

  2011cited by this paper
• Gastric bypass up-regulates insulin signaling pathway.

  2011cited by this paper
• Remission of Type 2 Diabetes After Gastric Bypass and Banding: Mechanisms and 2 Year Outcomes

  2010cited by this paper
• Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans

  2010cited by this paper
• Fasting Plasma Glucose in the Screening for Type 2 Diabetes in Morbidly Obese Subjects

  2010cited by this paper
• Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes.

  2010cited by this paper
• Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance.

  2010cited by this paper
• Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus

  2010influential reference
• Improvement in Glucose Metabolism After Bariatric Surgery: Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy: A Prospective Randomized Trial

  2009cited by this paper
• The Surgical Treatment of Type II Diabetes Mellitus: Changes in HOMA Insulin Resistance in the First Year Following Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) and Laparoscopic Adjustable Gastric Banding (LAGB)

  2009cited by this paper
• Prospective Study of Gut Hormone and Metabolic Changes After Adjustable Gastric Banding and Roux-en-Y Gastric Bypass

  2009cited by this paper
• Dual Mechanism for Type-2 Diabetes Resolution after Roux-en-Y Gastric Bypass

  2009cited by this paper
• Nutritional regulation of glucagon‐like peptide‐1 secretion

  2009cited by this paper
• Metabolic/Bariatric Surgery Worldwide 2008

  2009cited by this paper
• Incretin-based therapies for type 2 diabetes mellitus

  2009cited by this paper
• Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery

  2009cited by this paper
• Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.

  2008cited by this paper
• Regulation by glucose of oscillatory electrical activity and 5-HT/insulin release from single mouse pancreatic islets in absence of functional K(ATP) channels.

  2008cited by this paper
• Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

  2008cited by this paper
• Identification of Glucose-Dependent Insulin Secretion Targets in Pancreatic β Cells by Combining Defined-Mechanism Compound Library Screening and siRNA Gene Silencing

  2008cited by this paper
• Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas

  2008cited by this paper
• Improvement of Insulin Resistance After Obesity Surgery: A Comparison of Gastric Banding and Bypass Procedures

  2008cited by this paper
• Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.

  2007cited by this paper
• Short-term Effects of Sleeve Gastrectomy on Type 2 Diabetes Mellitus in Severely Obese Subjects

  2007cited by this paper
• Corelease and Differential Exit via the Fusion Pore of GABA, Serotonin, and ATP from LDCV in Rat Pancreatic β Cells

  2007cited by this paper
• 3H‐serotonin as a marker of oscillatory insulin secretion in clonal β‐cells (INS‐1)

  2007cited by this paper
• Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery

  2006cited by this paper
• Dopaminergic regulation of glucose‐induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro

  2006cited by this paper
• The unique cytoarchitecture of human pancreatic islets has implications for islet cell function

  2006cited by this paper
• The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes

  2006cited by this paper
• Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach.

  2006cited by this paper
• Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.

  2005cited by this paper
• Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.

  2005cited by this paper
• Results of Laparoscopic Sleeve Gastrectomy (LSG) at 1 Year in Morbidly Obese Korean Patients

  2005cited by this paper
• Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.

  2005cited by this paper
• Dopamine D2-like Receptors Are Expressed in Pancreatic Beta Cells and Mediate Inhibition of Insulin Secretion*

  2005cited by this paper
• Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes: A New Perspective for an Old Disease

  2004cited by this paper
• Effect of Lap-Band®-Induced Weight Loss on Type 2 Diabetes Mellitus and Hypertension

  2004cited by this paper
• Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

  2004cited by this paper
• DAncing past the DAT at a DA synapse.

  2004cited by this paper
• Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle.

  2004cited by this paper
• Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

  2003cited by this paper
• Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

  2003cited by this paper
• Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake.

  2002cited by this paper
• Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase.

  2002cited by this paper
• Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

  2001cited by this paper
• Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.

  2001cited by this paper
• Etiology of Type II Diabetes Mellitus: Role of the Foregut

  2001cited by this paper
• Triggering and amplifying pathways of regulation of insulin secretion by glucose.

  2000cited by this paper
• Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats.

  2000cited by this paper
• Autonomic regulation of islet hormone secretion – Implications for health and disease

  2000cited by this paper
• Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.

  2000cited by this paper
• Sources and physiological significance of plasma dopamine sulfate.

  1999cited by this paper
• Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.

  1999cited by this paper
• Substantial production of dopamine in the human gastrointestinal tract.

  1997cited by this paper
• Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle.

  1997cited by this paper
• New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin

  1997cited by this paper
• A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine.

  1996cited by this paper
• Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult‐Onset Diabetes Mellitus

  1995cited by this paper
• Neural regulation of the endocrine pancreas

  1995cited by this paper
• Dopamine formation, from its immediate precursor 3,4‐dihydroxyphenylalanine, along the rat digestive tract

  1993cited by this paper
• Inhibition of insulin secretion: a fail-safe system.

  1993cited by this paper
• Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

  1992cited by this paper
• The influence of meal composition on plasma serotonin and norepinephrine concentrations.

  1992cited by this paper
• Effect of L‐DOPA Administration on Islet Monoamine Oxidase Activity and Glucose‐Induced Insulin Release in the Mouse

  1991cited by this paper

• Amino Acid Metabolite Profiling for Predicting and Understanding the Metabolic Effects of Metabolic and Bariatric Surgery

  2025cites this paper
• Metabolomic Alterations in Patients with Obesity and the Impact of Metabolic Bariatric Surgery: Insights for Future Research

  2025cites this paper
• Dopamine Receptors and TAAR1 Functional Interaction Patterns in the Duodenum Are Impaired in Gastrointestinal Disorders

  2024cites this paper
• Molecular Pharmacology in Diabetes

  2024cites this paper
• Evidence for dopamine production and distribution of dopamine D2 receptors in the equine gastrointestinal mucosa and pancreas

  2024cites this paper
• Effect of short-term dopamine reduction on insulin sensitivity and post-prandial insulin and glucose responses in Standardbred horses.

  2024cites this paper
• Dopamine in the regulation of glucose and lipid metabolism: a narrative review

  2024cites this paper
• Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes

  2023cites this paper
• Circulating Dopamine Is Regulated by Dietary Glucose and Controls Glucagon-like 1 Peptide Action in White Adipose Tissue

  2023cites this paper
• Disruption of the dopaminergic system in the pathophysiology of diabetes mellitus

  2023cites this paper
• Subcutaneous adipose tissue dopamine D2 receptor is increased in prediabetes and T2D

  2023cites this paper
• A Novel and Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions

  2022cites this paper
• Roles of Pancreatic Islet Catecholamine Neurotransmitters in Glycemic Control and in Antipsychotic Drug-Induced Dysglycemia.

  2022cites this paper
• Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function

  2021cites this paper
• Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors

  2021cites this paper
• Diabetes, insulin and new therapeutic strategies for Parkinson's disease: focus on glucagon-like peptide-1 receptor agonists.

  2021cites this paper
• Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes

  2021cites this paper
• β-Catenin mediates glucose-dependent insulinotropic polypeptide increases in lysyl oxidase expression in osteoblasts

  2021cites this paper
• Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic Outcomes

  2021cites this paper
• Peripheral Focused Ultrasound Neuromodulation (pFUS).

  2020cites this paper
• Anti-incretin Effect: A Missing Link between Obesity, Diabetes, and Metabolic Surgery

  2020cites this paper
• Inhibition of Plasminogen Activator Inhibitor-1 Activation Suppresses High Fat Diet-Induced Weight Gain via Alleviation of Hypothalamic Leptin Resistance

  2020cites this paper
• Type 2 diabetes mellitus remission and its prediction after two-stage surgical treatment of patients with morbid obesity.

  2019cites this paper
• Problématique de la mesure de la pression artérielle en obésité sévère

  2019cites this paper
• Anti‐incretin effect: The other face of Janus in human glucose homeostasis

  2019influential citation
• Impaired Gastric Hormone Regulation of Osteoblasts and Lysyl Oxidase Drives Bone Disease in Diabetes Mellitus

  2019cites this paper
• Metabolic Surgery, Reality or Myth: Scientific Side of Obesity Pathophysiology and Management

  2018cites this paper
• The Role of Dopamine in Primary Headaches

  2018cites this paper